Literature DB >> 7003667

Immunoglobulin production in man stimulated by an orally administered bacterial lysate.

J M Puigdollers, G R Serna, I Hernandez del Rey, M T Barruffet, J J Torroella.   

Abstract

The concentrations of secretory immunoglobulins in the saliva, and of immunoglobulin in the serum, have been measured by the radial immunodiffusion method in 12 healthy volunteers, before and after oral administration of Broncho-Vaxom which is a lysate of bacteria that usually cause infection in the upper respiratory tract. The mean concentration of secretory IgA in the saliva was increased by over 100% after the 10-day administration of the product. This increase was statistically significant between the 20th and 33rd day after the beginning of the treatment (p < 0.05). It fell to a normal level after a month in 4 subjects who received one treatment course only. In 8 subjects who received a second treatment course beginning 1 month after termination of the first course, the high concentration of IgAs in the saliva persisted for at least 3 months. A significant increase in the serum concentrations of IgG of about 50% and of IgM of at least 100% above the initial level was observed in the treated subjects in the time between day 35 and 5 months after the beginning of the experiment (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003667     DOI: 10.1159/000194264

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Immunomodulation with bacterial extracts in respiratory diseases.

Authors:  A G Palma-Carlos; M L Palma-Carlos
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Broncho-Vaxom inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187.

Authors:  A Németh; P Magyar
Journal:  Agents Actions       Date:  1989-04

3.  OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells.

Authors:  Hong Luan; Qian Zhang; Le Wang; Chuanxiao Wang; Miao Zhang; Xiaoli Xu; Huan Zhou; Xing'ai Li; Qing Xu; Fan He; Jin Yuan; Yongman Lv
Journal:  J Interferon Cytokine Res       Date:  2014-03-07       Impact factor: 2.607

4.  Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly.

Authors:  N Debbas; J P Derenne
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.

Authors:  D Alecsandru; L Valor; S Sánchez-Ramón; J Gil; J Carbone; J Navarro; J Rodríguez; C Rodríguez-Sainz; E Fernández-Cruz
Journal:  Clin Exp Immunol       Date:  2011-04       Impact factor: 4.330

6.  Prevention of recurrent rhinopharyngitis in at-risk children in France: a cost-effectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV).

Authors:  Jean-Jacques Pessey; Françoise Mégas; Benoît Arnould; Florence Baron-Papillon
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom.

Authors:  Miao Zhang; Hong Luan; Qian Zhang; Le Wang; Yong-Man Lv; Fan He; Yan Chen; Hong-Bing Zeng; Ying Yao; Qin Liu
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

8.  Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine.

Authors:  R L Clancy; A W Cripps; A J Husband; D Buckley
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  [Not Available].

Authors:  M D Gutiérrez-Tarango; A Berber
Journal:  Clin Drug Investig       Date:  1997       Impact factor: 2.859

10.  Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency.

Authors:  Ferah Genel; Necil Kutukculer
Journal:  Curr Ther Res Clin Exp       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.